NCT07739095

Brief Summary

Weight loss is difficult and weight maintenance even worse. The principles of dieting dictate that to maintain weight loss, one has to eat less calories than they did before the diet. However, there is evidence to show that it may be the diet per se and not the weight loss that makes people more hungry and vulnerable to weight regain. This study will explore whether appetite control can be restored to normal levels through an individually tailored increase in calories after weight loss. If supported, the findings from this study could alter the way we view dieting.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
24mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

2 years

First QC Date

July 14, 2026

Last Update Submit

July 27, 2026

Conditions

Keywords

Appetiteweight lossexercisedietary intervention

Outcome Measures

Primary Outcomes (1)

  • Appetite measurements

    Desire to eat, hunger, fullness, and prospective food consumption (PFC) will be rated immediately before (after a 12 h overnight fast) and every 30 min\*3 h after the standardized breakfast on a 100-mm visual analog scale (VAS) adapted from Hill and Blundell. Scores range from 0 to 100 millimeters. For hunger, desire to eat, and prospective food consumption, higher scores indicate greater appetite. For fullness, higher scores indicate greater fullness (lower appetite). The satiety quotient will be calculated for each subject.

    Baseline (1 week before the dietary intervention), end of week 20 (after the weight-loss intervention), onset of week 25 (after the 1-month weight-maintenance period).

Secondary Outcomes (16)

  • Plasma concentrations of appetite-regulating hormones

    Blood samples will be collected at each experimental session: Baseline (1 week before the dietary intervention), end of week 20 (after the weight-loss intervention), and onset of week 25 (after the 1-month weight-maintenance period).

  • Resting Energy Expenditure

    Resting Energy Expenditure will be measured during the screening session (2 weeks before baseline), at baseline, end of week 20 (after the weight-loss intervention), onset of week 25 (after the 1-month weight-maintenance period).

  • Exercise Energy Expenditure

    Accelerometer: worn for 7 days at each sampling period (screening, week 20 (end of weight loss intervention), weeks 22 and 24 (middle and end of weight maintenance). Exercise energy expenditure will be measured once per week during weight maintenance.

  • Total Energy Expenditure

    The DLW dose will be consumed during the screening session, and participants will provide their first urine sample. A second sample will be collected on the following day, and a 3rd 7 days later.

  • Energy Intake

    In-lab energy intake: Baseline, end of week 20 (after the weight-loss intervention), and at the onset of week 25 (after one month of weight maintenance). Free-living energy intake will be measured for 3 days after the screening session.

  • +11 more secondary outcomes

Study Arms (2)

High Energy Flux

EXPERIMENTAL

After weight loss through a dietary intervention, the high flux group will remain in a state of energy balance through an increase in exercise and an increase in energy intake to pre-weight loss values.

Behavioral: ExerciseBehavioral: Dietary Intervention

Low Energy Flux

PLACEBO COMPARATOR

After weight loss through a dietary intervention, the low-energy flux group will remain in energy balance but at a lower energy flux, with no changes in exercise levels and energy intake remaining lower than pre-weight-loss values.

Behavioral: Dietary Intervention

Interventions

ExerciseBEHAVIORAL

Daily kilometer target at normal walking pace (\~5km/h). The American College of Sports Medicine (ACSM) metabolic equation for the caloric cost of walking will be used to assess the distance needed to be covered daily.

High Energy Flux

Participants will be prescribed a 20-week energy-restricted diet (-25% of energy requirements). A registered dietitian will be responsible for nutrition counselling and will use the Canadian Diabetes Association's Exchange System to prescribe the diet plan. During the weight loss phase, participants will receive a revised diet plan, based on the adjusted energy requirements that will account for the achieved weight loss. After weight loss, the diet plan will be revised based on the group (high-energy flux vs low-energy flux) to be in a state of energy balance.

High Energy FluxLow Energy Flux

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age;
  • non-smoking;
  • obese class I-II (30 kg/m2 ≤ BMI \< 40 kg/m2);
  • weight stable (± 2 kg during the 6 months prior to enrollment);
  • Sedentary (\<2 times/week of 30 min of continuous exercise)
  • In addition, Females will be included if:
  • \) premenopausal (2 menses in the 3 months preceding testing, no increase in cycle irregularity in the 12 months preceding testing).

You may not qualify if:

  • have a current diagnosis of an axis 1 psychiatric disorder (i.e. mood, anxiety and eating disorders);
  • currently use antidepressants, thyroid medication, or any medication that could affect appetite;
  • have a history of cardiac problems or symptoms suggestive of any cardiac condition;
  • have a current diagnosis or history of diabetes, confirmed by a measure of HbA1c during the screening visit;
  • have alcohol intake that exceeds recommendations or alcoholism, or current addictions to opiates, cocaine or stimulants;
  • currently taking monoamine oxidase inhibitors, pressor agents, warfarin, anticonvulsants, phenylbutazone, or tricyclic antidepressants;
  • have uncontrolled thyroid disease;
  • have any osteoarticular condition, or other reasons that would prevent them from achieving the proposed walking targets.
  • In addition, Females will be excluded if they:
  • are pregnant or planning to become pregnant over the course of the study;
  • are peri- or post-menopausal or have had surgically induced menopause.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa

Ottawa, Ontario, K1S 5S9, Canada

Location

Related Publications (9)

  • Machado AM, Guimaraes NS, Bocardi VB, da Silva TPR, Carmo ASD, Menezes MC, Duarte CK. Understanding weight regain after a nutritional weight loss intervention: Systematic review and meta-analysis. Clin Nutr ESPEN. 2022 Jun;49:138-153. doi: 10.1016/j.clnesp.2022.03.020. Epub 2022 Mar 31.

    PMID: 35623805BACKGROUND
  • Doucet E, McInis K, Mahmoodianfard S. Compensation in response to energy deficits induced by exercise or diet. Obes Rev. 2018 Dec;19 Suppl 1:36-46. doi: 10.1111/obr.12783.

    PMID: 30511511BACKGROUND
  • Cameron JD, Goldfield GS, Riou ME, Finlayson GS, Blundell JE, Doucet E. Energy depletion by diet or aerobic exercise alone: impact of energy deficit modality on appetite parameters. Am J Clin Nutr. 2016 Apr;103(4):1008-16. doi: 10.3945/ajcn.115.115584. Epub 2016 Feb 17.

    PMID: 26888712BACKGROUND
  • Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995 Mar 9;332(10):621-8. doi: 10.1056/NEJM199503093321001.

    PMID: 7632212BACKGROUND
  • Schwartz A, Doucet E. Relative changes in resting energy expenditure during weight loss: a systematic review. Obes Rev. 2010 Jul;11(7):531-47. doi: 10.1111/j.1467-789X.2009.00654.x. Epub 2009 Sep 17.

    PMID: 19761507BACKGROUND
  • Dulloo AG, Jacquet J, Girardier L. Poststarvation hyperphagia and body fat overshooting in humans: a role for feedback signals from lean and fat tissues. Am J Clin Nutr. 1997 Mar;65(3):717-23. doi: 10.1093/ajcn/65.3.717.

    PMID: 9062520BACKGROUND
  • Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001 Nov;74(5):579-84. doi: 10.1093/ajcn/74.5.579.

    PMID: 11684524BACKGROUND
  • Ryan DH. Risks and benefits of weight loss: challenges to obesity research. European Heart Journal 2005; (7): L27-L31.

    BACKGROUND
  • Anderson JW, Luan J, Hoie LH. Structured weight-loss programs: meta-analysis of weight loss at 24 weeks and assessment of effects of intervention intensity. Adv Ther. 2004 Mar-Apr;21(2):61-75. doi: 10.1007/BF02850334.

    PMID: 15310080BACKGROUND

MeSH Terms

Conditions

ObesityOverweightWeight LossMotor Activity

Interventions

ExerciseDiet Therapy

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutrition TherapyTherapeutics

Study Officials

  • Eric Doucet, PhD

    University of Ottawa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Noemie Beauregard, PhD (c)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 31, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

July 31, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations